LPCAT1 and prostate carcinoma: Moreover, high expression of the LPCAT1 gene has been implicated in the pathology of lung adenocarcinoma (49), breast cancer (50), prostate cancer (51), esophageal squamous cell carcinoma (52), and HCC (53), among other cancers.